Study #2009-0038
A Phase II Metastasectomy Study for Patients with Renal Cell Carcinoma
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase II trial studies the follow-up after metastasectomy in patients with kidney cancer. Following up patients' health condition after metastasectomy may help doctors to learn if the surgical removal of the primary tumor or the parts of the cancer that has spread to other parts of the body is a good method for treating patients who have kidney cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Renal Cell Carcinoma
Study phase:
Physician name:
Eric Jonasch
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-833-767-1887
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.